Federal Register / Vol. 63, No. 106 /Wednesday, June 3, 1998 / Notices 30231

prevention programs. The purpose of

the quarterly report is to report data

collected by CDC’s grantees. The report

consists of narrative and data sections.

The narrative section (1) provides

highlights of quarterly activities, (2)

reports issues and activities that have

significant impact on the program, and

(3) lists objectives and discusses

progress towards meeting those

objectives. The data section provides (1)

screening and case confirmation

activities, (2) environmental inspection

and hazard remediation activities, and

(3) medical case management activities.

The total cost to the respondents is

$0.00.

Respondents No. of respondents

No. of responses/respondentAvg. burden/

response (in

hrs.)

Total burden

(in hrs.)

Grantees ........................................................................................................... 41 4 2 328

Total ........................................................................................................... ........................ ........................ ........................ 328

3. Evaluation of Effectiveness of

Worker Notifications Conducted by

NIOSH—(New)—The National Institute

for Occupational Safety and Health

(NIOSH) has conducted worker

notification formally since 1988. This

program informs workers in NIOSHconducted epidemiological studies

about the study results and hence, of

their risks. NIOSH worker notification

officers conducted a two-task evaluation

project approved by OMB in 1993. Task

1 of the project evaluated the long-term

impact of a high risk worker

notification, and Task 2 evaluated the

short-term impact and effectiveness of

the notification materials themselves,

with the goal of developing a

monitoring instrument for routine use.

A monitoring instrument was developed

for routine use to evaluate effectiveness

of ongoing worker notification activities.

This instrument was refined over three

field trials, involving a random sample

set of 25 notified workers in each trial.

A second instrument for use with other

stakeholders (company and union

officials) in the notifications also was

developed. The design of these

evaluation projects was descriptive in

nature, gathering information from

small groups of workers, for the purpose

of learning how to improve the NIOSH

worker notification program.

Having completed the data collection

and final report for Task 2 of the

evaluation project, we now are seeking

approval to use the program monitoring

worker survey instrument on a routine

basis to assess effectiveness of ongoing

letter notifications conducted by NIOSH

notification officers. As with the design

of the three trials in Task 2, ongoing

routine assessment would include for

each letter-type notification, our

contacting by telephone a random

sample of 25 workers who received

notification letters and related materials,

and at least one company representative

and one union representative (where

appropriate). A 15-minute telephone

survey would be administered to the

notified workers, and an up to 30

minute interview would be conducted

with the other stakeholders (e.g.,

company and union representatives).

The total annual cost to respondents for

the study is $1187.50.

Respondents (workers) No. of respondents

No. of responses/respondent

Avg. burden/

response

Total burden (in

hrs.)

Task 1 ............................................................................................................. 750 1 .25 187.5

Task 2 ............................................................................................................. 60 1 .50 30

Total ......................................................................................................... ........................ ........................ ........................ 217.5

Dated: May 28, 1998.

Charles W. Gollmar,

Acting Associate Director for Policy Planning

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–14646 Filed 6–2–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 98063]

Notice of Availability of Funds;

Cooperative Agreement for National

Hepatitis B Immunization Program with

Focus on Asians and Pacific Islanders

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year FY 1998 funds

for a cooperative agreement to support

a Hepatitis B Immunization Project with

a focus on Asians and Pacific Islanders.

The purpose of this cooperative

agreement program is to increase

hepatitis B vaccination levels among

Asian and Pacific Islander (API)

children in the United States born

between 1983 and 1993 from a baseline

of 10 percent in 1996 to 90 percent by

the close of year 2000, to enhance local

demand for hepatitis B vaccination of

API children, and to inform and educate

vaccination service providers who serve

API children. This program addresses

the ‘‘Healthy People 2000’’ priority area

of Immunization, and Infectious

Diseases.

B. Eligible Applicants

Applications may be submitted by

public and private nonprofit (and forprofit) organizations, and by

governments and their agencies; that is,

universities, colleges, research

institutions, hospitals, other public and

private non profit organizations, State

and local governments or their bona fide

agents, and federally recognized Indian

tribal governments, Indian tribes, or

Indian tribal organizations.

Note: Public Law 104–65 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $49,900 is available in

FY 1998 to fund one award. It is

expected that the award will begin on or

about July 31, 1998, and will be made

for a 12-month budget period within a

project period of up to three years.

Funding estimates may change.
30232 Federal Register / Vol. 63, No. 106 /Wednesday, June 3, 1998 / Notices

Continuation awards within an

approved project period will be made

on the basis of satisfactory progress as

evidenced by required reports and the

availability of funds.

D. Program Requirements

In achieving the purpose of this effort,

the recipient will be responsible for the

activities listed under Item 1, (Recipient

Activities) and CDC will be responsible

for the activities listed under Item 2,

(CDC Activities).

1. Recipient Activities

The recipient will promote hepatitis B

immunization of all API children in the

United States through collaborative

education and vaccination activities and

sharing of information and resources

through the member groups, working

groups, volunteers, and national, State,

and local public and private health care

providers. The grantee will:

a. Recipient should conduct meetings,

form working groups, and maintain

reports and other records as necessary

related to Hepatitis B Immunization

activities.

b. Work with targeted national

organizations and State and local

coalitions to facilitate API hepatitis B

vaccination coverage surveys and

implementation of efforts to educate

providers and parents about hepatitis B

vaccine (HBV), Vaccines for Children

(VFC) Program, and the national

recommendations to vaccinate all API

children with hepatitis B vaccine.

c. Work with State and local

coalitions to identify barriers and

solutions to these barriers in the

implementation of hepatitis B

vaccination of all API children.

d. Regularly inform all work groups

and volunteers and relevant national,

State and local groups of recipient

related activities around the country

with a published vehicle such as a

newsletter.

e. Develop strategies, action plans,

and mechanisms to increase public and

private collaboration on activities to

ensure hepatitis B vaccination of all API

children in the U.S., for example, such

as establishing a Web page; organizing

volunteer groups; organizing fundraising efforts; developing and utilizing

mailing lists; working with Asian

language school principals; meeting

with Asian language media

spokespersons; and working through the

federal Vaccines for Children (VFC)

network to enroll and educate providers

of vaccination services to API children

in each of the 12 top API states—

California, New York, Hawaii, Texas,

Illinois, New Jersey, Washington,

Florida, Virginia, Maryland,

Pennsylvania, and Massachusetts.

f. Establish working relationships

with API health care providers to

enhance their interest and participation

in the project.

g. Devise and implement a linkage of

a majority of the existing hepatitis B

virus transmission prevention resources

with a majority of the nation’s API

community leaders.

2. Centers for Disease Control and

Prevention (CDC) Activities

a. As requested, provide assistance to

the recipient, with plans or agendas for

proposed activities.

b. Provide technical assistance

through telephone calls,

correspondence, and site visits in the

area of program and agenda

development, implementation, and

priority setting related to the

cooperative agreement.

c. Provide scientific collaboration for

appropriate aspects of the activities,

including information on disease impact

and vaccination coverage levels.

d. Provide speakers, when possible,

on such topics and impact of HBV

infection in API’s, national policy and

recommendations related to hepatitis B

vaccination of API children.

e. Assist as requested in reporting and

validating relevant hepatitis B

vaccination information made available

through publication in a newsletter and

journal articles and otherwise provided

to project members, volunteers, Federal,

State, and local health agencies, and

health care providers.

f. Provide representatives to attend

executive, steering group and work

group conference calls and meetings.

E. Application Content

The application must contain the

following:

1. Objectives consistent with the

existing purpose of the applicant

organization.

2. Background information on the

applicant; evidence of relevant

experience in coordinating groups of

diverse organizations; evidence of the

applicant’s organizational capacity and

experience in building and maintaining

relationships with national

organizations, private and public sector

non-profit health care organization,

professional health associations,

volunteer groups, advocacy groups, API

organizations, and government entities.

4. A clear description of the purpose

of the applicant organization along with

detailed methods and activities which

will be undertaken to ensure

vaccination of at least 90 percent of all

API children in the U.S. with hepatitis

B vaccine by the close of year 2000.

5. A plan to monitor and evaluate

activities.

6. Biographical information on

qualified and experienced

administrative and professional

personnel who will be working in an

existing organizational structure to

fulfill the terms of the project.

7. Letters from current API

organizations, API community leaders,

and State and local public health

agencies which indicate the applicant

has their support and involvement in

conducting the activities of this project

and has an established reputation to

motivate other organizations.

8. A detailed budget and narrative

budget justification.

Competing Applications

Use the information in the Program

Requirements, Other Requirements, and

Evaluation Criteria sections to develop

the application content. Your

application will be evaluated on the

criteria listed, so it is important to

follow them in laying out your program

plan. The narrative should be no more

than 30 double-spaced pages, printed on

one side, with one inch margins, and

unreduced font.

F. Submission and Deadline

Application

Submit the original and two copies of

PHS 5161–1 (OMB Number 0937–0189)

on or before July 6, 1998. Submit the

application to: David Elswick, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Announcement 98063,

Centers for Disease Control and

Prevention (CDC), Room 300, 255 East

Paces Ferry Road, NE., Mailstop E–13,

Atlanta, Georgia 30305–2209.

If your application does not arrive in

time for submission to the independent

review group, it will not be considered

in the current competition unless you

can provide proof that you mailed it on

or before the deadline (i.e., receipt from

U.S. Postal Service or a commercial

carrier; private metered postmarks are

not acceptable).

G. Evaluation Criteria

Each application will be evaluated by

an independent review group appointed

by CDC to the extent it documents the

applicant’s:

1. understanding of the existing

disease control problem and the

importance and feasibility of hepatitis B

vaccination of at least 90 percent of all

API children in the U.S. by the close of

year 2000. (10 percent)
Federal Register / Vol. 63, No. 106 /Wednesday, June 3, 1998 / Notices 30233

2. specific, realistic, measurable, and

time-phased objectives which are

related to effective activities. (15

percent)

3. high quality and effective plan for

ensuring implementation of State and

local successful hepatitis B vaccination

efforts in at least the top 12 API states.

(20 percent)

4. established network of national,

State or local collaborators and

accessibility to an adequate number of

member organization representatives.

(20 percent)

5. administrative and support staff to

operate the project. (10 percent)

6. qualified and experienced

professional personnel who are

committed to the project and will

implement the proposed program

activities. (10 percent)

7. appropriate and effective plan to

measure activities and evaluate its

progress toward the year 2000 goal. (15

percent)

In addition, consideration will be

given to the extent to which the budget

request is clearly justified and

consistent with the intended use of

cooperative agreement funds.

H. Other Requirements

Technical Reporting Requirements

A. Provide CDC with original plus

two copies of:

1. quarterly progress reports

describing the progress toward

achieving objectives, implementing

vaccination programs, and providing

services;

2. financial status report, no more

than 90 days after the end of the budget

period; and

3. final financial and performance

reports, no more than 90 days after the

end of the project period.

B. Provide an annual report to the

project members, summarizing activities

and accomplishments of the project.

Send all reports to: David Elswick,

Grants Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), Room

300, 255 East Paces Ferry Road, NE.,

Mailstop E–13, Atlanta, GA 30305–

2209.

The grantee will visit CDC, NIP at

least twice a year for a verbal progress

report on all project activities.

The following additional

requirements are applicable to this

program.

AR98–11 Healthy People 2000

AR98–12 Lobbying Restrictions

AR98–7 Executive Order 12372

Review

AR98–8 Public Health System

Reporting Requirements

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under the

Public Health Service Act, Section

317(k)(1)[42 U.S.C. 247b(k)(1)], as

amended. The Catalog of Federal

Domestic Assistance number is 93.185.

J. Where to Obtain Additional

Information

Please refer to Program

Announcement 98063 when you request

information. For a complete program

description, information on application

procedures, an application package, and

business management assistance,

contact: David Elswick, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Announcement 98063,

Centers for Disease Control and

Prevention (CDC), Room 300, 255 East

Paces Ferry Road, NE., Mailstop E–13,

Atlanta, GA 30305–2209, telephone

(404) 842–6521, Email address

DCE1@cdc.gov.

See also the CDC home page on the

Internet: http://www.cdc.gov

For program technical assistance,

contact Gary L. Euler, DrPH, Chief,

Hepatitis Activity, Adult Vaccine

Preventable Diseases Branch,

Epidemiology and Surveillance

Division, National Immunization

Program, Centers for Disease Control

and Prevention (CDC), 1600 Clifton

Road, NE., Mailstop E–61, Atlanta, GA

30333, telephone (404) 639–8742,

Internet address: GLE0@CDC.gov.

To receive additional written

information and to request an

application kit, call 1–888–GRANTS4

(1–888 472–6874). You will be asked to

leave your name and address and will

be instructed to identify the

Announcement number of interest.

Dated: May 28, 1998.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention.

[FR Doc. 98–14658 Filed 6–2–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Program Announcement No. 98043;

National Partnerships for Human

Immunodeficiency Virus (HIV)

Prevention; Notice of Availability of

Funds for Fiscal Year 1998

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1998

funds to (a) develop national, State, and

local leadership and support for HIV

prevention programs and policies, and

(b) build capacity and skills for HIV

prevention activities at the State and

local levels.

This announcement relates to the

priority areas of educational and

community-based programs, HIV

infection, and sexually transmitted

diseases (STDs). It addresses the

‘‘Healthy People 2000’’ objectives by

providing support for primary

prevention for persons at risk for HIV

infection and by increasing the

availability and coordination of

prevention and early intervention

services for HIV-infected persons. CDC

encourages all grant recipients to

provide HIV prevention education to

their employees and staff.

B. Eligible Applicants

To be eligible for funding under this

announcement, applicants must be (1) a

tax-exempt, non-profit national

business-or labor-related, religion-or

faith-based, performing arts,

professional media, or civic or service

organization , as defined below, whose

net earnings in no part accrue to the

benefit of any private shareholder or

person; or (2) an academic institution

working in collaboration with such

organizations. Tax-exempt status is

determined by the Internal Revenue

Service (IRS) Code, Section 501(c)(3).

Tax-exempt status may be proved by

either providing a copy of the pages

from the IRS’ most recent list of

501(c)(3) tax-exempt organizations or a

copy of the current IRS Determination

Letter. Proof of tax-exempt status must

be provided with the application. CDC

will not accept an application without

proof of tax-exempt status.

For purposes of this cooperative

agreement, the following definitions are

used:

A national business-or labor-related

organization is a non-profit,

professional or voluntary organization,

that (1) has businesses, business leaders,